| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |